REQUEST A DEMO
Total
USD $0.00
Search more companies

JW Cayman Therapeutics Company Limited (Hong Kong SAR, China)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Full name: JW Cayman Therapeutics Company Limited Profile Updated: September 08, 2021
Buy our report for this company USD 29.95 Most recent financial data: 2020 Available in: English & Chinese Download a sample report

JW Cayman Therapeutics Company Limited focuses on clinical & preclinical cell therapy. The company develops an integrated cellular immunotherapy platform for blood cancer and solid tumors. The company was established in 2017 and headquartered in Shanghai City, China.

Headquarters
31st Floor, Tower Two, Times Square, 1 Matheson Street, Causeway Bay, Hong Kong
Hong Kong; Hong Kong;

Contact Details: Purchase the JW Cayman Therapeutics Company Limited report to view the information.

Website: http://www.jwtherapeutics.com/

Basic Information
Total Employees:
Purchase the JW Cayman Therapeutics Company Limited report to view the information.
Outstanding Shares:
Purchase the JW Cayman Therapeutics Company Limited report to view the information.
Registered Capital:
Purchase the JW Cayman Therapeutics Company Limited report to view the information.
Financial Auditors:
Purchase the JW Cayman Therapeutics Company Limited report to view the information.
Ratings:
Purchase the JW Cayman Therapeutics Company Limited report to view the information.
Incorporation Date:
September 06, 2017
Key Executives
Purchase this report to view the information.
Non-Executive Director
Purchase this report to view the information.
Non-Executive Director
Purchase this report to view the information.
Non-Executive Director
Purchase this report to view the information.
Non-Executive Director
Purchase this report to view the information.
Non-Executive Director
Ownership Details
Purchase this report to view the information.
18.65%
Purchase this report to view the information.
12.08%
Purchase this report to view the information.
6.05%
Subsidiaries
Company Performance
Financial values in the chart are available after JW Cayman Therapeutics Company Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Operating profit (EBIT)
56.88%
Net Profit (Loss) for the Period
56.82%
Total assets
72.11%
Total equity
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
N/A
Quick Ratio
7.06%
Cash Ratio
6.86%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?